Information
-
Trademark
-
79399425
-
Serial Number
79399425
-
Registration Number
7617325
-
International Classifications
-
Filing Date
May 31, 2024
10 months ago
-
Registration Date
December 24, 2024
3 months ago
-
Transaction Date
February 07, 2025
a month ago
-
Status Date
December 24, 2024
3 months ago
-
Published for Opposition Date
November 05, 2024
5 months ago
-
Location Date
December 23, 2024
3 months ago
-
Status Code
700
-
Current Location
FILE REPOSITORY (FRANCONIA)
Employee Name
SMITH,CAROLINE P
-
-
Owners
Mark Drawing Code
4
Mark Identification
LIVAZEBE
Case File Statements
- GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain.
Case File Event Statements
-
7/5/2024 - 9 months ago
1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Type: SDRC
-
7/9/2024 - 9 months ago
2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED
Type: LIMI
-
7/12/2024 - 8 months ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
10/16/2024 - 5 months ago
7 - NOTICE OF PUBLICATION
Type: NPUB
-
7/12/2024 - 8 months ago
4 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
9/16/2024 - 6 months ago
5 - ASSIGNED TO EXAMINER
Type: DOCK
-
9/24/2024 - 6 months ago
6 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/5/2024 - 5 months ago
8 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
12/24/2024 - 3 months ago
9 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
1/23/2025 - 2 months ago
10 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR